Literature DB >> 21301109

Preparation, crystallization and preliminary X-ray diffraction analysis of two intestinal fatty-acid binding proteins in the presence of 11-(dansylamino)undecanoic acid.

Aisha Laguerre1, Jerome Wielens, Michael W Parker, Christopher J H Porter, Martin J Scanlon.   

Abstract

Fatty-acid binding proteins (FABPs) are abundantly expressed proteins that bind a range of lipophilic molecules. They have been implicated in the import and intracellular distribution of their ligands and have been linked with metabolic and inflammatory responses in the cells in which they are expressed. Despite their high sequence identity, human intestinal FABP (hIFABP) and rat intestinal FABP (rIFABP) bind some ligands with different affinities. In order to address the structural basis of this differential binding, diffraction-quality crystals have been obtained of hIFABP and rIFABP in complex with the fluorescent fatty-acid analogue 11-(dansylamino)undecanoic acid.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301109      PMCID: PMC3034631          DOI: 10.1107/S1744309110051481

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  21 in total

1.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 2.  Intracellular lipid-binding proteins and their genes.

Authors:  D A Bernlohr; M A Simpson; A V Hertzel; L J Banaszak
Journal:  Annu Rev Nutr       Date:  1997       Impact factor: 11.848

Review 3.  New insights into the structure and function of fatty acid-binding proteins.

Authors:  A W Zimmerman; J H Veerkamp
Journal:  Cell Mol Life Sci       Date:  2002-07       Impact factor: 9.261

4.  Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parameters.

Authors:  Andrew Rowland; Kathleen M Knights; Peter I Mackenzie; John O Miners
Journal:  Drug Metab Dispos       Date:  2009-04-27       Impact factor: 3.922

5.  Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids.

Authors:  A C Young; G Scapin; A Kromminga; S B Patel; J H Veerkamp; J C Sacchettini
Journal:  Structure       Date:  1994-06-15       Impact factor: 5.006

6.  Refined apoprotein structure of rat intestinal fatty acid binding protein produced in Escherichia coli.

Authors:  J C Sacchettini; J I Gordon; L J Banaszak
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.

Authors:  L J Baier; J C Sacchettini; W C Knowler; J Eads; G Paolisso; P A Tataranni; H Mochizuki; P H Bennett; C Bogardus; M Prochazka
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

8.  Solution structure of human intestinal fatty acid binding protein with a naturally-occurring single amino acid substitution (A54T) that is associated with altered lipid metabolism.

Authors:  Fengli Zhang; Christian Lücke; Leslie J Baier; James C Sacchettini; James A Hamilton
Journal:  Biochemistry       Date:  2003-06-24       Impact factor: 3.162

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

1.  Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods.

Authors:  Manoochehr Khazaee; Emerson Christie; Weixiao Cheng; Mandy Michalsen; Jennifer Field; Carla Ng
Journal:  Toxics       Date:  2021-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.